See more : Integrated Services Group Inc (ISVG) Income Statement Analysis – Financial Results
Complete financial analysis of Deccan Health Care Limited (DECCAN.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Deccan Health Care Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Macmahon Holdings Limited (MAH.AX) Income Statement Analysis – Financial Results
- Deezer S.A. (DEEZR.PA) Income Statement Analysis – Financial Results
- SIPP International Industries, Inc. (SIPN) Income Statement Analysis – Financial Results
- Taiwan Secom Co., Ltd. (9917.TW) Income Statement Analysis – Financial Results
- KOIKE-YA Inc. (2226.T) Income Statement Analysis – Financial Results
Deccan Health Care Limited (DECCAN.BO)
About Deccan Health Care Limited
Deccan Health Care Ltd. develops, manufactures, and markets wellness products to healthcare professionals. Its products include the brands Oxyflax, Ostan-G, Ostan, Lycocare, Nulife, Co-Q Plus, Fatigue Buster, Zorovit-M, Minicare, Maxicare, Ostoheatlth Plus, and Lotorin. The company was founded by Minto P. Gupta on June 14, 1996 and is headquartered in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 597.29M | 450.22M | 331.71M | 337.76M | 422.44M | 442.48M | 378.27M | 294.00M | 172.22M | 91.49M | 70.41M | 94.08M |
| Cost of Revenue | 375.72M | 317.66M | 199.76M | 241.20M | 237.01M | 208.53M | 177.25M | 131.96M | 77.26M | 36.46M | 29.82M | 50.87M |
| Gross Profit | 221.57M | 132.56M | 131.95M | 96.56M | 185.43M | 233.95M | 201.02M | 162.04M | 94.96M | 55.03M | 40.60M | 43.21M |
| Gross Profit Ratio | 37.10% | 29.44% | 39.78% | 28.59% | 43.89% | 52.87% | 53.14% | 55.12% | 55.14% | 60.15% | 57.65% | 45.93% |
| Research & Development | 0.00 | 134.00K | 127.00K | 473.00K | 5.71M | 603.00K | 2.28M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 36.24M | 126.34M | 90.25M | 80.81M | 77.14M | 74.03M | 67.98M | 46.42M | 27.73M | 13.21M | 21.13M | 23.54M |
| Other Expenses | 0.00 | -10.00K | 0.00 | -9.56M | 0.00 | -3.47M | -3.03M | 0.00 | 107.00K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 36.24M | 126.48M | 90.38M | 90.84M | 82.85M | 78.10M | 73.29M | 46.42M | 27.62M | 50.22M | 78.69M | 91.16M |
| Cost & Expenses | 411.96M | 444.14M | 290.14M | 332.04M | 319.86M | 286.62M | 250.54M | 178.38M | 104.88M | 86.68M | 108.51M | 142.03M |
| Interest Income | 0.00 | 84.00K | 39.00K | 76.00K | 136.00K | 50.00K | 98.00K | 116.00K | 13.00K | 15.15M | 14.90M | 14.80M |
| Interest Expense | 850.00K | 1.10M | 1.52M | 1.08M | 1.83M | 10.36M | 14.98M | 21.44M | 14.78M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 14.67M | 14.28M | 14.73M | 14.66M | 14.17M | 12.86M | 12.81M | 11.91M | 11.51M | 11.51M | 11.50M | 11.46M |
| EBITDA | 37.51M | 19.84M | 57.63M | 20.62M | 116.75M | 168.20M | 140.54M | 127.53M | 78.74M | 18.24M | -26.59M | -36.46M |
| EBITDA Ratio | 6.28% | 4.52% | 16.97% | 6.03% | 27.64% | 38.13% | 37.15% | 43.38% | 45.78% | 19.94% | -37.76% | -38.93% |
| Operating Income | 185.33M | 6.07M | 41.57M | 5.72M | 102.58M | 155.86M | 127.73M | 115.63M | 67.33M | 6.73M | -38.09M | -48.09M |
| Operating Income Ratio | 31.03% | 1.35% | 12.53% | 1.69% | 24.28% | 35.22% | 33.77% | 39.33% | 39.10% | 7.36% | -54.09% | -51.12% |
| Total Other Income/Expenses | -163.19M | -1.68M | -36.15M | -525.00K | -1.26M | -10.19M | -76.65M | -20.95M | -16.59M | -17.07M | -14.90M | -14.65M |
| Income Before Tax | 22.14M | 5.17M | 5.43M | 5.19M | 101.32M | 145.67M | 133.45M | 94.67M | 50.74M | -10.34M | -52.99M | -62.75M |
| Income Before Tax Ratio | 3.71% | 1.15% | 1.64% | 1.54% | 23.98% | 32.92% | 35.28% | 32.20% | 29.46% | -11.31% | -75.25% | -66.69% |
| Income Tax Expense | 7.21M | 1.53M | 2.20M | 1.29M | 444.00K | 863.00K | -150.00K | -203.00K | 73.00K | 537.00K | 1.33M | 2.09M |
| Net Income | 14.93M | 3.64M | 3.23M | 3.90M | 100.87M | 144.81M | 133.60M | 94.88M | 50.67M | -10.88M | -54.31M | -64.83M |
| Net Income Ratio | 2.50% | 0.81% | 0.97% | 1.15% | 23.88% | 32.73% | 35.32% | 32.27% | 29.42% | -11.89% | -77.13% | -68.91% |
| EPS | 0.80 | 0.22 | 0.21 | 0.25 | 6.42 | 10.29 | 10.26 | 5.95 | 3.18 | -2.04 | -10.19 | -12.16 |
| EPS Diluted | 0.80 | 0.22 | 0.21 | 0.25 | 6.42 | 10.29 | 10.26 | 5.95 | 3.18 | -2.04 | -10.19 | -12.16 |
| Weighted Avg Shares Out | 18.66M | 16.77M | 15.71M | 15.71M | 15.71M | 14.08M | 13.02M | 15.93M | 15.93M | 5.33M | 5.33M | 5.33M |
| Weighted Avg Shares Out (Dil) | 18.61M | 16.77M | 15.71M | 15.71M | 15.71M | 14.08M | 13.02M | 15.93M | 15.93M | 5.33M | 5.33M | 5.33M |
Source: https://incomestatements.info
Category: Stock Reports